Vaxart Inc VXRT

Healthcare Biotechnology

Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its development programs include pill vaccines designed to protect against norovirus (cause for acute gastroenteritis), coronavirus, including SARS-CoV-2 (COVID-19)), and influenza. In addition, it has generated preclinical data for its therapeutic vaccine candidate targeting cervical cancer and dysplasia caused by human papillomavirus. The Company's platform technology employs a vector-based approach and consists of various components, such as a vector (adenovirus type 5 (Ad5); an antigen (Ad5 DNA); an adjuvant (Toll-like receptor 3 (TLR3)), and its proprietary enteric-coated tablet.

NDAQ:VXRT - Post by User

Vaxart Inc

Bullboard Posts

Post by corOWNaviruson Mar 11, 2020 4:32pm

172 Views

Post# 30795440

CORONAVIRUS STOCKS ONLY PLAY IN TOWN

Simply put this is the greatest event since World War II All Coronavirus related stocks even the penny stocks remotely related to anything CORONAVIRUS WILL EXPLODE TO THE UPSIDE Greatest opportunity in a lifetime, unfortunately it is a virus that will kill many millions! This will not go away it will get enormous the cheapest stocks will give the biggest profits Good Luck to all

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week